Literature DB >> 23807641

Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions.

Marco Massani1, Tommaso Stecca, Luca Fabris, Ezio Caratozzolo, Cesare Ruffolo, Alberto Furlanetto, Stuart Morton, Massimiliano Cadamuro, Mario Strazzabosco, Nicolò Bassi.   

Abstract

Cholangiocarcinoma (CCA) is a devastating malignancy arising from the bile ducts. Cancer-associated fibroblasts (CAFs) are key players in CCA invasiveness and in the generation of a desmoplastic reaction. The aim of the present study was to develop a novel model by which to study tumor-stroma interactions using primary cultures of human biliary epithelial cells (hBECs) and stromal cells (SCs) in CCA. hBECs and SCs, isolated from surgical resections (n=10), were semi-purified by centrifugation on a Percoll gradient; hBECs were further immunopurified. hBECs and SCs were characterized using epithelial [cytokeratin 7 (CK7) and CK19] and mesenchymal [vimentin (VMN), α-smooth muscle actin (α-SMA), CD68] cell markers. The purity of cultured cells was assessed by fluorescent immunocytochemistry. hBECs were HEA125/CK7/CK19-positive and VMN/α-SMA-negative. SCs were VMN/α-SMA-positive and CK7/CK19-negative. CCA 2-D culture models have been described but they use long-standing CCA cell lines of various biliary tumor cell origins with stromal cells derived from non-cholangiocarcinoma tissues. Recently, a novel 3-D organotypic co-culture model of rat cholangiocarcinoma was described. In the present study, we obtained pure and stable primary cultures of hBECs and SCs from CCA surgical specimens. These cell cultures may provide a useful tool by which to study CCA tumor-stroma interactions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23807641     DOI: 10.3892/or.2013.2568

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  16 in total

Review 1.  Cholangiocarcinoma 2020: the next horizon in mechanisms and management.

Authors:  Jesus M Banales; Jose J G Marin; Angela Lamarca; Pedro M Rodrigues; Shahid A Khan; Lewis R Roberts; Vincenzo Cardinale; Guido Carpino; Jesper B Andersen; Chiara Braconi; Diego F Calvisi; Maria J Perugorria; Luca Fabris; Luke Boulter; Rocio I R Macias; Eugenio Gaudio; Domenico Alvaro; Sergio A Gradilone; Mario Strazzabosco; Marco Marzioni; Cédric Coulouarn; Laura Fouassier; Chiara Raggi; Pietro Invernizzi; Joachim C Mertens; Anja Moncsek; Sumera Rizvi; Julie Heimbach; Bas Groot Koerkamp; Jordi Bruix; Alejandro Forner; John Bridgewater; Juan W Valle; Gregory J Gores
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-06-30       Impact factor: 46.802

2.  Transforming Growth Factors α and β Are Essential for Modeling Cholangiocarcinoma Desmoplasia and Progression in a Three-Dimensional Organotypic Culture Model.

Authors:  Miguel Á Manzanares; Akihiro Usui; Deanna J Campbell; Catherine I Dumur; Gabrielle T Maldonado; Michel Fausther; Jonathan A Dranoff; Alphonse E Sirica
Journal:  Am J Pathol       Date:  2017-03-15       Impact factor: 4.307

Review 3.  Cholangiocarcinoma: increasing burden of classifications.

Authors:  Vincenzo Cardinale; Maria Consiglia Bragazzi; Guido Carpino; Alessia Torrice; Alice Fraveto; Raffaele Gentile; Vincenzo Pasqualino; Fabio Melandro; Camilla Aliberti; Carlo Bastianelli; Roberto Brunelli; Pasquale Bartolomeo Berloco; Eugenio Gaudio; Domenico Alvaro
Journal:  Hepatobiliary Surg Nutr       Date:  2013-10       Impact factor: 7.293

Review 4.  Epigenetic control of the tumor microenvironment.

Authors:  David L Marks; Rachel Lo Olson; Martin E Fernandez-Zapico
Journal:  Epigenomics       Date:  2016-10-04       Impact factor: 4.778

5.  Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) in a single patient: A case report.

Authors:  Rongxing Zhou; Minjia Zhang; Nansheng Cheng; Yong Zhou
Journal:  Oncol Lett       Date:  2015-11-10       Impact factor: 2.967

6.  Liver Tumor Microenvironment.

Authors:  Diamantis I Tsilimigras; Ioannis Ntanasis-Stathopoulos; Dimitrios Moris; Timothy M Pawlik
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

7.  Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation.

Authors:  Stuart Duncan Morton; Massimiliano Cadamuro; Simone Brivio; Marta Vismara; Tommaso Stecca; Marco Massani; Nicolò Bassi; Alberto Furlanetto; Ruth Elizabeth Joplin; Annarosa Floreani; Luca Fabris; Mario Strazzabosco
Journal:  Oncotarget       Date:  2015-09-22

Review 8.  Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth.

Authors:  Kazuyoshi Shiga; Masayasu Hara; Takaya Nagasaki; Takafumi Sato; Hiroki Takahashi; Hiromitsu Takeyama
Journal:  Cancers (Basel)       Date:  2015-12-11       Impact factor: 6.639

9.  Myofibroblasts Derived from Hepatic Progenitor Cells Create the Tumor Microenvironment.

Authors:  Sayaka Sekiya; Shizuka Miura; Kanae Matsuda-Ito; Atsushi Suzuki
Journal:  Stem Cell Reports       Date:  2016-12-01       Impact factor: 7.765

10.  Activation of Fas/FasL pathway and the role of c-FLIP in primary culture of human cholangiocarcinoma cells.

Authors:  Gianluca Carnevale; Guido Carpino; Vincenzo Cardinale; Alessandra Pisciotta; Massimo Riccio; Laura Bertoni; Lara Gibellini; Sara De Biasi; Lorenzo Nevi; Daniele Costantini; Diletta Overi; Andrea Cossarizza; Anto de Pol; Eugenio Gaudio; Domenico Alvaro
Journal:  Sci Rep       Date:  2017-10-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.